Published on 17/02/2010
Medical developments in the US could lead to the development of a new generation of biomedical implants that avoid the risk of bone rejection.
Researchers at North Carolina State University have created light-weight 'metal foam' with elasticity similar to that of natural bone.
Co-author of the report Dr Afsaneh Rabiei explained that the new composite material could benefit patients by reducing the likelihood of revision surgery associated with traditional implants.
He said: "When an orthopedic or dental implant is placed in the body to replace a bone or a part of a bone, it needs to handle the loads in the same way as its surrounding bone.
"If the modulus of elasticity of the implant is too much bigger than the bone, the implant will take over the load bearing and the surrounding bone will start to die. This will cause the loosening of the implant and eventually ends in failure."
The metal foam can be used as an alternative to more rigid implant material such as titanium.
© ActiveQuote Health Ltd. 2010
Categories: Medical
Related Health Insurance News Articles
02/02/2012Prostate cancer drug Abiraterone turned down by NICE, but available for patients with private medical coverAbiraterone, a drug that extends the life of prostate cancer sufferers, has been provisionally rejected for use on the NHS. However, it will still be available to patients with private medical insurance . ...
03/02/2012Bupa, AXA PPP, WPA and Aviva will cover prostate cancer drug AbirateroneAfter we previously reported that prostate cancer drug abiraterone has been deemed by NICE as too expensive for use on the NHS, health insurers are now coming forward to offer cover for the drug. NICE had...
08/02/2012Hospital superbug C. difficle source is unclear, say scientistsScientists cannot explain how 75 per cent of people catch the superbug C. difficile, after a study showed that only a quarter of infections in one hospital system were traced to contact with a suffering...
09/02/2012Coronary heart disease gene is passed from father to sonUp to one in five men is carrying a gene from their father that increases their risk of coronary heart disease by 50 per cent. A study has found that men can inherit a form of heart disease from their father...
09/02/2012Fasting paired with chemotherapy significantly slows the growth of cancer cellsAn interesting new study indicates that starvation paired with chemotherapy can significantly reduce the growth of cancer cells, matching or improving the effects of chemotherapy alone. Scientists at the...